Today on DrugResearcher.com   Speedel puts its eggs in renin inhibitor basket RBM buys EDI, simplifies immune response testing Last throw of the dice for NPS Pharmaceuticals? China luring preclinical players GSK hopes boron drugs can tackle pathogen resistance

Related Industry News   AMRI embraces India Docetaxel head to head GE Healthcare introduces new bioprocessing products Drug delivery sponging the nanoscale

Breaking News on Drug Discovery
Daily  Wednesday 10 October 2007		Forward to a colleague

	Company Profile ClonePix FL - explore cell surfaces discover stellar clones ClonePix FL technology makes light-work of selecting and isolating mammalian cell clones by cell surface protein expression, rapidly yielding monoclonal populations for cell based assays, screening, downstream phenotyping/genotyping and basic discovery research... Click Here Access Full Stories Speedel puts its eggs in renin inhibitor basket As Speedel's fourth renin inhibitor enters clinical trials, this award-winning new class of drugs has generally been well-received. However, some have raised questions about their safety and effectiveness. DrugResearcher.com... Read RBM buys EDI, simplifies immune response testing Biomarker testing service provider Rules-Based Medicine (RBM) has bought EDI to gain access to its 3D organ-like and ex vivo cell culture test systems to aid its preclinical and clinical research programmes... Read Last throw of the dice for NPS Pharmaceuticals? NPS pharmaceuticals has ended its collaboration with pharma giant AstraZeneca, selling the rights to the partnership for $30m (€21.2m) in order to fund development of its late-stage products... Read China luring preclinical players China is one of the best destinations to outsource preclinical work, delegates heard at this year's CPhI trade how in Milan... Read GSK hopes boron drugs can tackle pathogen resistance GlaxoSmithKline (GSK) thinks that drugs based on boron, rather than carbon, could side-step the issue of resistance in anti-bacterial and anti-viral therapy - and is willing to bet billions on it... Read
	All News Headlines for: October | September | August
	Technical / White Paper Manufacturing Variations in Polysorbate Batches Lot to lot variances in a series of Polysorbate preparations was easily and clearly differentiated and identified by utilizing charged aerosol detection (CAD), a new universal detectorfor HPLC... Click Here
	Related Industry News AMRI embraces India US-based contract manufacturer AMRI has been busily embracing India with the purchase and construction of infrastructure to cement itself in this popular location, delegates heard at this year's CPhI in Milan... Read Docetaxel head to head Two manufacturers launched their docetaxel products at CPhI last week, each trying to stake their claim in the market in anticipation of patent expiries on Sanofi-Aventis' Taxotere (docetaxel) towards the end of... Read GE Healthcare introduces new bioprocessing products UK-based GE Healthcare is introducing nine new product lines for biopharmaceutical production... Read Drug delivery sponging the nanoscale Forget the washing up, the sponge could soon be used to deliver drugs - but on the nanoscale... Read Weekly Comment FDA told its safety monitoring of clinical trials not good enough The US Food and Drug Administration (FDA) has been called into question again after the release of a damning report, this time suggesting the agency is inadequate in its safety monitoring of clinical trials. Read Product Presentation Rapid HPLC method development with ChromSword®Auto software Avoid the tedious search for good HPLC methods for separation with ChromSword®Auto's quicker chromatography solutions... Click Here Previous Headlines A 'virtual immune system' for drug developers A group of scientists are using real-world experimental data to generate a virtual model of the human immune system, which could then be used in drug design... Read US firm unveils new cell culture services US drug discovery firm BioProcessors has unveiled a new range of cell culture services to assist in biopharmaceutical process development... Read Rumours of Pfizer, Sanofi mega-merger emerge Rumours that Pfizer is looking into buying a large stake in Sanofi-Aventis, which could be seen as a prelude to a full takeover bid, has prompted a flurry of shareholder activity... Read Proteomics shows 3D cell cultures are better than 2D German researchers have shown 3D cell structures better resemble tumour phenotypes than traditional cultures, suggesting they will make better models for testing new anticancer agents... Read Fathers of 'targeted genetics' scoop Nobel prize The discoverer of embryonic stem cells (ES cells) and two other scientists have won a Nobel Prize for their work to develop a 'magic wand' to modify the mouse genome... Read Product Information - brochures, Web centers Separation of polar compounds - Application Notes Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com